publication venue for
- World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part I: Anxiety disorders. 24:79-117. 2023
- World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part II: OCD and PTSD. 24:118-134. 2023
- Mitochondria’s role in sleep: Novel insights from sleep deprivation and restriction studies. 23:1-13. 2022
- The World Federation of Societies of Biological Psychiatry (WFSBP) 2020 guidelines for the pharmacological treatment of paraphilic disorders. 21:412-490. 2020
- Circadian genes in major depressive disorder. 21:80-90. 2020
- Improving collaboration between primary care and mental health services. 20:748-765. 2019
- No detectable effects of acute tryptophan depletion on short-term immune system cytokine levels in healthy adults. 20:416-423. 2019
- WFSBP guidelines on how to grade treatment evidence for clinical guideline development. 20:2-16. 2019
- The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the treatment of adolescent sexual offenders with paraphilic disorders. 17:2-38. 2016
- The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the biological treatment of paraphilias. 11:604-655. 2010
- Lower rates of comorbidities in euthymic bipolar patients. 10:474-479. 2009
- Lower rates of comorbidities in euthymic bipolar patients. 10:474-479. 2009
- Misdiagnosis of bipolar disorder as borderline personality disorder: clinical and economic consequences. 10:612-615. 2009
- Turning order into chaos through repetition and addition of elementary acts in obsessive-compulsive disorder (OCD). 10:480-487. 2009
- Turning order into chaos through repetition and addition of elementary acts in obsessive-compulsive disorder (OCD). 10:480-487. 2009
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision. 9:248-312. 2008